Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Gastrointestinal Stromal Tumors × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Refractory Differentiated Thyroid Gland Carcinoma 1 Neoplasm Metastasis 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Renal Cell 1

Interventions

Imatinib Mesylate 5 regorafenib 1 cabozantinib 1 brostallicin 1 Trabectedin 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02216578 2021-07-15

Ph II CABOGIST in GIST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡